Abbott Laboratories (ABL) Q3 2022 Earnings Report
DE:ABL Q3 2022 EPS Results
- Actual EPS
- EUR 1.02
- Consensus EPS
- EUR 0.84
- Beat/Miss
- Beat by +EUR 0.18
- One Year Ago EPS
- EUR 1.25
DE:ABL Q3 2022 Revenue Results
- Actual Revenue
- EUR 9.28B
- Expected Revenue
- EUR 8.60B
- Beat/Miss
- Beat by +EUR 678.30M
- YoY Revenue Growth
- -4.74%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 10/19/2022
- Time
- Before Open
- Conference Call
- Wednesday, October 19, 2022
DE:ABL Upcoming Earnings
Abbott Laboratories's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:ABL Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ABL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 27, 2027 | 2026 (Q4) | 1.46- | 1.34 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 1.271.27 | 1.16 | 9.23% (+0.11) | |
| Jul 16, 2026 | 2026 (Q2) | 1.141.17 | 1.12 | 3.97% (+0.04) | |
| Apr 16, 2026 | 2026 (Q1) | 1.021.02 | 0.97 | 5.50% (+0.05) | |
| Jan 22, 2026 | 2025 (Q4) | 1.331.34 | 1.19 | 11.94% (+0.14) | |
| Oct 15, 2025 | 2025 (Q3) | 1.161.16 | 1.08 | 7.44% (+0.08) | |
| Jul 17, 2025 | 2025 (Q2) | 1.121.12 | 1.02 | 10.53% (+0.11) | |
| Apr 16, 2025 | 2025 (Q1) | 0.960.97 | 0.87 | 11.22% (+0.10) | |
| Jan 22, 2025 | 2024 (Q4) | 1.201.19 | 1.06 | 12.61% (+0.13) | |
| Oct 16, 2024 | 2024 (Q3) | 1.071.08 | 1.02 | 6.14% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed